AAAAAA

   
Results: 1-16 |
Results: 16
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma
Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma, CLIN EXP AL, 31(4), 2001, pp. 616-624
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids
Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids, CHEST, 119(4), 2001, pp. 1021-1026
Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis
Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis, ANN ALLER A, 85(2), 2000, pp. 111-114
Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma
Authors: Wilson, AM Orr, LC Sims, EJ Dempsey, OJ Lipworth, BJ
Citation: Am. Wilson et al., Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma, AM J R CRIT, 162(4), 2000, pp. 1297-1301
Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate - Relationship to asthma severity and beta(2)-receptor genotype
Authors: Fowler, SJ Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Sj. Fowler et al., Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate - Relationship to asthma severity and beta(2)-receptor genotype, AM J R CRIT, 162(4), 2000, pp. 1318-1322
Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow
Authors: Wilson, A Dempsey, OJ Sims, EJ Coutie, WJR Paterson, MC Lipworth, BJ
Citation: A. Wilson et al., Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow, CLIN EXP AL, 30(6), 2000, pp. 833-838
Intravenous montelukast in acute asthma: expensive aminophylline?
Authors: Dempsey, OJ Lipworth, BJ
Citation: Oj. Dempsey et Bj. Lipworth, Intravenous montelukast in acute asthma: expensive aminophylline?, THORAX, 55(9), 2000, pp. 808-809
Leukotriene receptor antagonist therapy
Authors: Dempsey, OJ
Citation: Oj. Dempsey, Leukotriene receptor antagonist therapy, POSTG MED J, 76(902), 2000, pp. 767-773
Functional antagonism with formoterol and salmeterol in asthmatic patientsexpressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism
Authors: Lipworth, BJ Dempsey, OJ Aziz, I
Citation: Bj. Lipworth et al., Functional antagonism with formoterol and salmeterol in asthmatic patientsexpressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism, CHEST, 118(2), 2000, pp. 321-328
Additive bronchoprotective and bronchodilator effects with single doses ofsalmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids
Authors: Dempsey, OJ Wilson, AM Sims, EJ Mistry, C Lipworth, BJ
Citation: Oj. Dempsey et al., Additive bronchoprotective and bronchodilator effects with single doses ofsalmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids, CHEST, 117(4), 2000, pp. 950-953
Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype
Authors: Lipworth, BJ Dempsey, OJ Aziz, I Wilson, AM
Citation: Bj. Lipworth et al., Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype, AM J MED, 109(2), 2000, pp. 114-121
Spacer devices increase dose of inhaled corticosteroids delivered
Authors: Dempsey, OJ Wilson, AM Lipworth, BJ
Citation: Oj. Dempsey et al., Spacer devices increase dose of inhaled corticosteroids delivered, BR MED J, 318(7200), 1999, pp. 1764-1764
Severe alpha(1)-antitrypsin deficiency and pregnancy
Authors: Dempsey, OJ Godden, DJ Martin, PD Danielian, PJ
Citation: Oj. Dempsey et al., Severe alpha(1)-antitrypsin deficiency and pregnancy, EUR RESP J, 13(6), 1999, pp. 1492-1494
Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids
Authors: Wilson, AM Dempsey, OJ Coutie, WJR Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids, LANCET, 353(9170), 1999, pp. 2128-2128
Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate
Authors: Dempsey, OJ Coutie, WJR Wilson, AM Williams, P Lipworth, BJ
Citation: Oj. Dempsey et al., Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate, THORAX, 54(7), 1999, pp. 614-617
Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler
Authors: Dempsey, OJ Wilson, AM Coutie, WJR Lipworth, BJ
Citation: Oj. Dempsey et al., Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler, CHEST, 116(4), 1999, pp. 935-940
Risultati: 1-16 |